Skip to Content

FINALLY! Dabigatran reversal!

Having recognized that their "wonder drug anticoagulant" was resulting in numerous exsanguination issues in primarily elderly folks prone to fall, Boehringer found a new way to make money- drug reversal with a monoclonal. Good for them- as long as it keeps our patients alive. But remind me why we don't use the readily reversible warfarin more often...


Post new comment

The content of this field is kept private and will not be shown publicly.